JESSICA WELLER: Open Payments
NPI 1699154567 · ROGERS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$473 in 28 payments from 11 companies in 2025. Trend: 2023 $1,922 · 2024 $576 · 2025 $473
Food & beverage: $473
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 6 | $96 |
| Amgen Inc. | 5 | $89 |
| Novartis Pharmaceuticals Corporation | 5 | $81 |
| PFIZER INC. | 3 | $51 |
| E.R. Squibb & Sons, L.L.C. | 3 | $43 |
| Edwards Lifesciences Corporation | 1 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Boston Scientific Corporation | 1 | $19 |
| BridgeBio Pharma, Inc. | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: VERQUVO, REPATHA, LEQVIO, ELIQUIS, SAPIEN 3 Ultra RESILIA, Kerendia, VYNDAQEL, Ranger.
Industry payments across AR — which companies pay providers there.
